ZyVersa Therapeutics, Inc.
ZVSA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001859007
No open-market purchases or sales by ZyVersa Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in ZyVersa Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +4 vs. Q2 2022
- Shares held
- 7.34M
- +1.07M (+17.2%) vs. Q2 2022
- Total value
- $73.3M
- +$11.1M (+17.8%) vs. Q2 2022
- New holders
- 4
- 4 more added
- Sold out
- 0
- 1 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZVSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $1 |
| Q2 2025 | 6 | $44.7K |
| Q1 2025 | 7 | $43.9K |
| Q4 2024 | 8 | $86.2K |
| Q3 2024 | 6 | $7.22K |
| Q2 2024 | 4 | $38.7K |
| Q1 2024 | 8 | $84.9K |
| Q4 2023 | 6 | $181.4K |
| Q3 2023 | 12 | $161.8K |
| Q2 2023 | 11 | $73.4K |
| Q1 2023 | 6 | $273.5K |
| Q4 2022 | 2 | $123.9K |
| Q3 2022 | 29 | $73.3M |
| Q2 2022 | 25 | $62.2M |
| Q1 2022 | 21 | $55.4M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding ZyVersa Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Street LLC | 392 | $4.00K | 0.00% | +305+350.6% | Added |
| Elequin Capital LP | 1,000 | $10.0K | 0.00% | +1,000 | New |
| Ancora Advisors, LLC | 2,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 5,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 12,000 | $120.0K | 0.03% | 00.0% | Unchanged |
| EHP Funds Inc. | 17,126 | $171.0K | 0.04% | 00.0% | Unchanged |
| OTA Financial Group L.P. | 29,030 | $290.0K | 0.25% | +29,030 | New |
| Karpus Management, Inc. | 43,225 | $432.0K | 0.02% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 50,000 | $500.0K | 0.01% | 00.0% | Unchanged |
| Glazer Capital, LLC | 92,693 | $926.0K | 0.02% | +8,954+10.7% | Added |
| Janus Henderson Group PLC | 105,000 | $1.05M | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 138,629 | $1.39M | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 176,900 | $1.77M | 0.05% | 00.0% | Unchanged |
| CNH Partners LLC | 183,093 | $1.83M | 0.04% | 00.0% | Unchanged |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 200,000 | $2.00M | 0.02% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 249,822 | $2.50M | 0.02% | +197,311+375.8% | Added |
| CVI Holdings, LLC | 249,900 | $2.50M | 0.19% | 00.0% | Unchanged |
| Rivernorth Capital Management, LLC | 274,996 | $2.75M | 0.12% | +274,996 | New |
| Periscope Capital Inc. | 292,305 | $2.92M | 0.09% | 00.0% | Unchanged |
| Kim, LLC | 350,000 | $3.50M | 0.16% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 362,613 | $3.62M | 0.05% | −3,000−0.8% | Reduced |
| MMCAP International Inc. SPC | 370,000 | $3.70M | 0.29% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 386,970 | $3.86M | 0.01% | 00.0% | Unchanged |
| Context Capital Management, LLC | 493,972 | $4.94M | 0.33% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 553,150 | $5.53M | 0.81% | +553,150 | New |
| Saba Capital Management, L.P. | 596,780 | $5.97M | 0.08% | +12,500+2.1% | Added |
| Cohanzick Management, LLC | 700,000 | $6.94M | 1.68% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 700,000 | $6.99M | 0.07% | 00.0% | Unchanged |
| RiverPark Advisors, LLC | 700,000 | $7.00M | 2.27% | 00.0% | Unchanged |